CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 805 of 859
Non-Antibody Products
Page 805 of 859
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Toxin A from Clostridium difficile | An enterotoxin that inactivates host Rho family GTPases by glucosylation,… | 100 µg | 19664-100 | More Info |
| Toxin B from Clostridium difficile | A cytotoxin that inactivates host Rho family GTPases by glucosylation, alt… | 50 µg | 19665-50 | More Info |
| Toyocamycin (hydrate) | A natural adenosine analog that prevents IRE1α-induced mRNA cleavage… | 1 mg | 17371-1 | More Info |
| Toyocamycin (hydrate) | A natural adenosine analog that prevents IRE1α-induced mRNA cleavage… | 10 mg | 17371-10 | More Info |
| Toyocamycin (hydrate) | A natural adenosine analog that prevents IRE1α-induced mRNA cleavage… | 25 mg | 17371-25 | More Info |
| Toyocamycin (hydrate) | A natural adenosine analog that prevents IRE1α-induced mRNA cleavage… | 5 mg | 17371-5 | More Info |
| Tozadenant | An adenosine A2A receptor antagonist (Kis = 11.5 and 6 nM for human and rh… | 10 mg | 28452-10 | More Info |
| Tozadenant | An adenosine A2A receptor antagonist (Kis = 11.5 and 6 nM for human and rh… | 100 mg | 28452-100 | More Info |
| Tozadenant | An adenosine A2A receptor antagonist (Kis = 11.5 and 6 nM for human and rh… | 25 mg | 28452-25 | More Info |
| Tozadenant | An adenosine A2A receptor antagonist (Kis = 11.5 and 6 nM for human and rh… | 50 mg | 28452-50 | More Info |
| TP-0463518 | A pan HIF-PH inhibitor; inhibits human HIF-PH1 (Ki = 5.3 nM), as well as h… | 10 mg | 33788-10 | More Info |
| TP-0463518 | A pan HIF-PH inhibitor; inhibits human HIF-PH1 (Ki = 5.3 nM), as well as h… | 25 mg | 33788-25 | More Info |
| TP-0463518 | A pan HIF-PH inhibitor; inhibits human HIF-PH1 (Ki = 5.3 nM), as well as h… | 5 mg | 33788-5 | More Info |
| TP-0463518 | A pan HIF-PH inhibitor; inhibits human HIF-PH1 (Ki = 5.3 nM), as well as h… | 50 mg | 33788-50 | More Info |
| TP-064 | A potent inhibitor of PRMT4 (IC50 50 = 43 nM) in vitro, | 1 mg | 20256-1 | More Info |
| TP-064 | A potent inhibitor of PRMT4 (IC50 50 = 43 nM) in vitro, | 10 mg | 20256-10 | More Info |
| TP-064 | A potent inhibitor of PRMT4 (IC50 50 = 43 nM) in vitro, | 25 mg | 20256-25 | More Info |
| TP-064 | A potent inhibitor of PRMT4 (IC50 50 = 43 nM) in vitro, | 5 mg | 20256-5 | More Info |
| TP-0903 | An inhibitor of Axl (IC50 = 27 nM ); exhibits greater than 50% inhibition… | 1 mg | 28757-1 | More Info |
| TP-0903 | An inhibitor of Axl (IC50 = 27 nM ); exhibits greater than 50% inhibition… | 10 mg | 28757-10 | More Info |
| TP-0903 | An inhibitor of Axl (IC50 = 27 nM ); exhibits greater than 50% inhibition… | 25 mg | 28757-25 | More Info |
| TP-0903 | An inhibitor of Axl (IC50 = 27 nM ); exhibits greater than 50% inhibition… | 5 mg | 28757-5 | More Info |
| TP-3654 | A Pim kinase inhibitor (Kis = 5, 239, and 42 nM for Pim-1, Pim-2, and Pim-… | 10 mg | 29571-10 | More Info |
| TP-3654 | A Pim kinase inhibitor (Kis = 5, 239, and 42 nM for Pim-1, Pim-2, and Pim-… | 25 mg | 29571-25 | More Info |
| TP-3654 | A Pim kinase inhibitor (Kis = 5, 239, and 42 nM for Pim-1, Pim-2, and Pim-… | 5 mg | 29571-5 | More Info |
| TP-472 | A BRD9 inhibitor (Kd = 33 nM; EC50 = 320 nM in a NanoBRET assay); >30-fold… | 1 mg | 20030-1 | More Info |
| TP-472 | A BRD9 inhibitor (Kd = 33 nM; EC50 = 320 nM in a NanoBRET assay); >30-fold… | 5 mg | 20030-5 | More Info |
| TP-4748 | A heterocyclic building block; has been used in the synthesis of prolyl-tR… | 10 mg | 31459-10 | More Info |
| TP-4748 | A heterocyclic building block; has been used in the synthesis of prolyl-tR… | 25 mg | 31459-25 | More Info |
| TP-4748 | A heterocyclic building block; has been used in the synthesis of prolyl-tR… | 50 mg | 31459-50 | More Info |
| TP-808 | An intermediate in the synthesis of synthetic tetracycline antibiotics, | 100 mg | 24181-100 | More Info |
| TP-808 | An intermediate in the synthesis of synthetic tetracycline antibiotics, | 250 mg | 24181-250 | More Info |
| TP-808 | An intermediate in the synthesis of synthetic tetracycline antibiotics, | 50 mg | 24181-50 | More Info |
| TP53BP1 BRCT domains (human, recombinant) | Source: Recombinant human N-terminal GST-tagged protein expressed in E. co… | 100 µg | 14171-100 | More Info |
| TP53BP1 BRCT domains (human, recombinant) | Source: Recombinant human N-terminal GST-tagged protein expressed in E. co… | 25 µg | 14171-25 | More Info |
| TP53BP1 BRCT domains (human, recombinant) | Source: Recombinant human N-terminal GST-tagged protein expressed in E. co… | 50 µg | 14171-50 | More Info |
| TP53BP1 tudor-like region (human recombinant) | Source: Recombinant N-terminal GST-tagged protein expressed in E. coli &bu… | 100 µg | 14073-100 | More Info |
| TPCA-1 | A selective inhibitor of IKK2 (IC50s = 17.9 nM and 0.40 µM for IKK2… | 1 mg | 15115-1 | More Info |
| TPCA-1 | A selective inhibitor of IKK2 (IC50s = 17.9 nM and 0.40 µM for IKK2… | 10 mg | 15115-10 | More Info |
| TPCA-1 | A selective inhibitor of IKK2 (IC50s = 17.9 nM and 0.40 µM for IKK2… | 5 mg | 15115-5 | More Info |
| TPCA-1 | A selective inhibitor of IKK2 (IC50s = 17.9 nM and 0.40 µM for IKK2… | 500 µg | 15115-500 | More Info |
| TPEN | A metal ion chelator used in zinc treatment studies to limit intra- and ex… | 10 mg | 13340-10 | More Info |
| TPEN | A metal ion chelator used in zinc treatment studies to limit intra- and ex… | 100 mg | 13340-100 | More Info |
| TPEN | A metal ion chelator used in zinc treatment studies to limit intra- and ex… | 25 mg | 13340-25 | More Info |
| TPEN | A metal ion chelator used in zinc treatment studies to limit intra- and ex… | 50 mg | 13340-50 | More Info |
| TP-238 (hydrochloride) | A chemical probe for CECR2 and BPTF bromodomains; has on-target biochemica… | 1 mg | 27254-1 | More Info |
| TP-238 (hydrochloride) | A chemical probe for CECR2 and BPTF bromodomains; has on-target biochemica… | 10 mg | 27254-10 | More Info |
| TP-238 (hydrochloride) | A chemical probe for CECR2 and BPTF bromodomains; has on-target biochemica… | 5 mg | 27254-5 | More Info |
| TPI-1 | An inhibitor of protein tyrosine phosphatases; increases phosphorylated su… | 1 mg | 22480-1 | More Info |
| TPI-1 | An inhibitor of protein tyrosine phosphatases; increases phosphorylated su… | 10 mg | 22480-10 | More Info |
| TPI-1 | An inhibitor of protein tyrosine phosphatases; increases phosphorylated su… | 25 mg | 22480-25 | More Info |
| TPI-1 | An inhibitor of protein tyrosine phosphatases; increases phosphorylated su… | 5 mg | 22480-5 | More Info |
| Tpl2 Kinase Inhibitor | A Tpl2 inhibitor (IC50 = 0.05 µM); selective for Tpl2 over MEK, p38… | 1 mg | 19710-1 | More Info |
| Tpl2 Kinase Inhibitor | A Tpl2 inhibitor (IC50 = 0.05 µM); selective for Tpl2 over MEK, p38… | 10 mg | 19710-10 | More Info |
| Tpl2 Kinase Inhibitor | A Tpl2 inhibitor (IC50 = 0.05 µM); selective for Tpl2 over MEK, p38… | 25 mg | 19710-25 | More Info |
| Tpl2 Kinase Inhibitor | A Tpl2 inhibitor (IC50 = 0.05 µM); selective for Tpl2 over MEK, p38… | 5 mg | 19710-5 | More Info |
| Tpl2 Kinase Inhibitor (hydrochloride) | A Tpl2 inhibitor (IC50 = 0.05 µM); selective for Tpl2 over MEK, p38… | 1 mg | 34059-1 | More Info |
| Tpl2 Kinase Inhibitor (hydrochloride) | A Tpl2 inhibitor (IC50 = 0.05 µM); selective for Tpl2 over MEK, p38… | 10 mg | 34059-10 | More Info |
| Tpl2 Kinase Inhibitor (hydrochloride) | A Tpl2 inhibitor (IC50 = 0.05 µM); selective for Tpl2 over MEK, p38… | 25 mg | 34059-25 | More Info |
| Tpl2 Kinase Inhibitor (hydrochloride) | A Tpl2 inhibitor (IC50 = 0.05 µM); selective for Tpl2 over MEK, p38… | 5 mg | 34059-5 | More Info |
| TPMPA (hydrate) | A selective GABAA-ρ1 (ρ1 GABAC) receptor antagonist (Kbs = 2 and 1… | 1 mg | 24302-1 | More Info |
| TPMPA (hydrate) | A selective GABAA-ρ1 (ρ1 GABAC) receptor antagonist (Kbs = 2 and 1… | 10 mg | 24302-10 | More Info |
| TPMPA (hydrate) | A selective GABAA-ρ1 (ρ1 GABAC) receptor antagonist (Kbs = 2 and 1… | 25 mg | 24302-25 | More Info |
| TPMPA (hydrate) | A selective GABAA-ρ1 (ρ1 GABAC) receptor antagonist (Kbs = 2 and 1… | 5 mg | 24302-5 | More Info |
| TPP-1 (hydrochloride) | A peptide inhibitor of the PD-1-PD-L1 protein-protein interaction; binds t… | 1 mg | 37410-1 | More Info |
| TPP-1 (hydrochloride) | A peptide inhibitor of the PD-1-PD-L1 protein-protein interaction; binds t… | 10 mg | 37410-10 | More Info |
| TPP-1 (hydrochloride) | A peptide inhibitor of the PD-1-PD-L1 protein-protein interaction; binds t… | 25 mg | 37410-25 | More Info |
| TPP-1 (hydrochloride) | A peptide inhibitor of the PD-1-PD-L1 protein-protein interaction; binds t… | 5 mg | 37410-5 | More Info |
| TPPU | A potent inhibitor of both human and mouse soluble epoxide hydrolase (IC50… | 1 mg | 11120-1 | More Info |
| TPPU | A potent inhibitor of both human and mouse soluble epoxide hydrolase (IC50… | 10 mg | 11120-10 | More Info |
| TPPU | A potent inhibitor of both human and mouse soluble epoxide hydrolase (IC50… | 25 mg | 11120-25 | More Info |
| TPPU | A potent inhibitor of both human and mouse soluble epoxide hydrolase (IC50… | 5 mg | 11120-5 | More Info |
| TP Receptor (human) Blocking Peptide | Antigen: human TP receptor C-terminal amino acids 323-343 (LSTRPRSLSLQPQLT… | 1 ea | 10009368-1 | More Info |
| TP Receptor (mouse) Blocking Peptide | Peptide Sequence: amino acids 275-289 (VMSFSGQLLRATEHQ) · To be use… | 1 ea | 10004110-200 | More Info |
| TPT-260 (hydrochloride) | A thiophene thiourea derivative that acts as a chaperone to stabilize the… | 1 mg | 16079-1 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile